China Medical Technologies, Inc. (CMED)
F2Q 2011 (09/30/11) Earnings Conference Call
November 18, 2011 8:00 AM EST
Winnie Yam – IR
Charles Zhu – SVP, Operations
Sam Tsang – CFO
Xiaodong Wu – CEO
Jack Hu – Deutsche Bank
Chris Lui – Morgan Stanley
Thank you for standing by. Welcome to the second quarter 2011 China Medical Technologies’ earnings conference call.
At this time, all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session. (Operator Instructions). I must advise you that this conference is being recorded today, November 18
I would now like to hand the conference over to your speaker today, Ms. Winnie Yam. Please go ahead.
Good day, ladies and gentlemen. I am pleased to welcome you to China Medical earnings conference call. China Medical already announced its second fiscal quarter financial results ended September 30
, 2011. A copy of the press release is also available on the company’s website at
Today, your speakers will be Mr. Xiaodong Wu, CEO; Mr. Sam Tsang, CFO; and Mr. Charles Zhu, Senior VP of Operations. After they finish with their remarks, they will be available to answer your question.
Before we continue, please bear with me as I take you through the company’s Safe Harbor policy. The discussion today will contain forward-looking statements made under the Safe Harbor Provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements involve inherent risk and uncertainty. As such, the results may be materially different from the views expressed today. A number of potential risk and uncertainties are outlined in the company’s public filings with the US Securities and Exchange Commission.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts